DND1 anticorps (Middle Region)
Aperçu rapide pour DND1 anticorps (Middle Region) (ABIN951954)
Antigène
Voir toutes DND1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 197-226, Middle Region
-
Specificité
- This antibody recognizes Human DND1 (Center).
-
Purification
- Affinity Chromatography on Protein A
-
Immunogène
- KLH conjugated synthetic peptide between 197-226 amino acids from the Central region of Human DND1
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- DND1 (Dead End Homolog 1 (DND1))
-
Autre désignation
- DND1 / RBMS4
-
Sujet
- This gene encodes a protein that binds to microRNA-targeting sequences of mRNAs, inhibiting microRNA-mediated repression. Reduced expression of this gene has been implicated in tongue squamous cell carcinoma. Two pseudogenes of this gene are located on the long arm of chromosome 17.Synonyms: Dead end protein homolog 1, RNA-binding motif single-stranded-interacting protein 4
-
Poids moléculaire
- 38687 Da
-
ID gène
- 373863
-
NCBI Accession
- NP_919225
Antigène
-